Nigeria: Federal Govt Grants Provisional Approval for Oxford Malaria Vaccine

OMS / S. Hawkey
(file photo).
17 April 2023

The federal government of Nigeria has granted provisional approval for the R21/Matrix malaria vaccine developed by the Oxford University.

Director-general of the National Agency for Food and Drug Administration And Control (NAFDAC), Prof. Mojisola Adeyeye, disclosed this at a press briefing on Monday in Abuja.

This came days after Ghana became the first country to approve the vaccine, which is manufactured by the Serum Institute of India Pvt Ltd.

Adeyeye said the vaccine was indicated for prevention of clinical malaria in children from five months to three years of age, adding that the storage temperature of the vaccine is 2-8 °C.

"The R21 Malaria vaccine is an Adjuvanted protein vaccine presented as a sterile solution. A dose which is 0.5ml is composed of R21 Malaria antigen 5µg and Matrix-M1 50µg as an adjuvant filled in a vial as ready to use liquid formulation for intramuscular injection.

"The vaccine is indicated for prevention of clinical malaria in children from five months to 36 months of age. The storage temperature of the vaccine is 2-8 °C," she said.

She noted that the Agency's pathway for registration of vaccines were in line with its guideline for registration of Imported Drugs, Vaccines and IVDs under Collaborative Registration Procedure.

"The R21 Malaria Vaccine was reviewed using the later which involves full review of product dossiers," the NAFDAC DG explained.

AllAfrica publishes around 500 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.